These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 26744308

  • 1. MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
    Wang F, Yu D, Liu Z, Wang R, Xu Y, Cui H, Zhao T.
    Technol Cancer Res Treat; 2016 Dec; 15(6):NP105-NP112. PubMed ID: 26744308
    [Abstract] [Full Text] [Related]

  • 2. MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.
    Liu Y, Zhu ST, Wang X, Deng J, Li WH, Zhang P, Liu BS.
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP40-8. PubMed ID: 26306402
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.
    Zhu Z, Tang J, Wang J, Duan G, Zhou L, Zhou X.
    PLoS One; 2016 Oct; 11(3):e0150026. PubMed ID: 27019355
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells.
    Liu M, Xiusheng H, Xiao X, Wang Y.
    Oncol Rep; 2016 Dec; 36(6):3371-3378. PubMed ID: 27779704
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.
    Wang L, Kang FB, Sun N, Wang J, Chen W, Li D, Shan BE.
    Tumour Biol; 2016 Nov; 37(11):14939-14947. PubMed ID: 27644254
    [Abstract] [Full Text] [Related]

  • 16. miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells.
    Wang Y, Zhao W, Fu Q.
    Mol Cell Biochem; 2013 Dec; 384(1-2):105-11. PubMed ID: 23975506
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
    Wang Y, Zhang S, Xu Y, Zhang Y, Guan H, Li X, Li Y, Wang Y.
    Tumour Biol; 2016 Nov; 37(11):15211-15220. PubMed ID: 27683056
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.
    Tian X, Zhang J, Yan L, Dong JM, Guo Q.
    Int J Clin Exp Pathol; 2015 Nov; 8(6):6442-9. PubMed ID: 26261520
    [Abstract] [Full Text] [Related]

  • 20. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF, Jiang YQ, Li C, Dai XK, Wu T, Yin WZ.
    Cancer Biomark; 2020 Nov; 28(2):231-246. PubMed ID: 32508321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.